<p>/PRNewswire/ -- Marcus D. Goncalves, MD, PhD，被任命为纽约大学朗格尼医疗中心霍尔曼内分泌、糖尿病和代谢学部的主任。他接替自 2014 年以来一直领导该部门的 Ira J. Goldberg, MD，并将继续担任教职。</p>
<p>继续阅读</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null"/></p>
<p>Marcus Goncalves, MD, PhD</p>
<p>Goncalves 博士于 2024 年从威尔康奈尔医学院和纽约长老会医院加入纽约大学朗格尼。他还担任纽约大学格罗斯曼医学院内科学系的克拉丽莎和埃德加·布朗夫曼副教授及系统代谢研究主任，并在放射肿瘤学系担任副教授。作为一名全国知名的内分泌学家和医学科学家，他领导着一个强大的研究项目，专注于代谢、癌症和内分泌信号传导的交叉领域。他的研究推动了对包括恶病质、肥胖、胰岛素抵抗以及饮食糖（如果糖）代谢效应等疾病的理解，始终关注将发现转化为更好的患者护理。</p>
<p>“Goncalves 博士是一位杰出的领导者，他的工作体现了创新研究与临床卓越的结合，” 纽约大学格罗斯曼医学院内科学系的弗雷德里克·H·金内科学教授 Steven Abramson 博士说。“他带来了前瞻性的愿景，将增强该部门的学术形象，同时扩大其在患者护理、教育和发现方面的影响。”</p>
<p>作为主任，Goncalves 博士将指导该部门的临床、研究和培训任务。优先事项包括增强纽约大学朗格尼在糖尿病、甲状腺和垂体疾病方面的综合项目；扩大骨骼健康、肥胖和癌症相关恶病质的多学科倡议；以及增加研究者发起和行业赞助的临床试验组合，以加速科学发现向新疗法的转化。</p>
<p>“我很荣幸能领导这个部门，并在 Goldberg 博士和我们的教职员工建立的卓越基础上继续发展，” Goncalves 博士说。“我们的目标是通过创新的临床试验、扩展和完善我们的亚专业项目，以及促进多学科合作，带来最好的科学成果，为我们的患者提供新疗法和更好的结果，同时巩固纽约大学朗格尼作为复杂内分泌护理目的地的地位。”</p>
<p>这一领导层的过渡是在 Goldberg 博士的杰出任期之后，他监督了霍尔曼部门的卓越增长和创新。在他的领导下，纽约大学朗格尼扩大了曼哈顿、布鲁克林和长岛的内分泌护理服务；招募了一代新的临床教育者和医学科学家；并推动了在糖尿病、脂质紊乱、甲状腺疾病以及垂体和肾上腺疾病方面的全国认可项目。在他的领导下，自 2021 年以来，纽约大学朗格尼在《美国新闻与世界报道》中被评为全国糖尿病和内分泌护理的前五名。</p>
<p>“我们对 Goldberg 博士的卓越领导和对内分泌学的新贡献深表感谢，” Abramson 博士补充道。“他塑造了一个处于临床护理和发现前沿的部门。其临床项目和研究企业的实力使该部门——以及 Goncalves 博士——能够继续取得成功。”</p>
<p>在此基础上，Goncalves 博士将进一步发展内分泌学与癌症交叉领域的项目，反映他在代谢、癌症和内分泌信号传导交叉领域的研究。他将与肿瘤学、放射肿瘤学及其他专业的同事密切合作，以增强对肥胖、胰岛素抵抗、癌症相关恶病质及其他复杂代谢和内分泌疾病患者的护理，同时扩大纽约大学朗格尼的转化和临床研究机会。</p>
<p><strong>关于纽约大学朗格尼医疗中心</strong></p>
<p>纽约大学朗格尼医疗中心是一个完全整合的健康系统，通过对质量的严格关注，始终实现最佳患者结果，导致其在全国拥有一些最低的死亡率。Vizient, Inc.已连续四年将纽约大学朗格尼评为全国 118 家综合学术医疗中心中的第一名，而《美国新闻与世界报道》最近将其四个临床专业评为全国第一。纽约大学朗格尼提供一系列全面的医疗服务，在七个住院地点、其 Perlmutter 癌症中心以及纽约地区和佛罗里达州的 320 多个门诊地点提供统一的高标准护理。该系统还包括两所免学费的医学院，分别位于曼哈顿和长岛，以及一个庞大的研究企业。</p>
<p><strong>媒体咨询</strong></p>
<p>Katie Ullman</p>
<p>电话：646-483-3984</p>
<p>[email protected]</p>
<p>来源：纽约大学朗格尼医疗中心</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMjE5Jk5ld3NJdGVtSWQ9UEg5MTc1OSZUcmFuc21pc3Npb25fSWQ9MjAyNjAyMTkxMzU4UFJfTkVXU19VU1BSX19fX19QSDkxNzU5?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMjE5Jk5ld3NJdGVtSWQ9UEg5MTc1OSZUcmFuc21pc3Npb25fSWQ9MjAyNjAyMTkxMzU4UFJfTkVXU19VU1BSX19fX19QSDkxNzU5"/></p>

<p>马库斯·D·冈萨尔维斯博士被任命为纽约大学朗格尼医学中心内分泌学、糖尿病和代谢学霍尔曼部门的新主任，接替艾拉·J·戈德堡博士。冈萨尔维斯博士此前来自威尔康奈尔医学中心，旨在提升糖尿病、甲状腺和肥胖的临床项目，同时扩展研究计划。他的领导预计将增强该部门的学术形象并改善患者护理。纽约大学朗格尼医学中心因其高质量的医疗服务而受到认可，并在《美国新闻与世界报道》中被评为多个专业的顶尖机构</p>

<p>, /PRNewswire/ -- Marcus D. Goncalves, MD, PhD, has been appointed director of the Holman Division of Endocrinology, Diabetes, and Metabolism at NYU Langone Health. He succeeds Ira J. Goldberg, MD, who has led the division since 2014 and will continue as a member of the faculty.</p>
<div class="lb-trans"><p>/PRNewswire/ -- Marcus D. Goncalves, MD, PhD，被任命为纽约大学朗格尼医疗中心霍尔曼内分泌、糖尿病和代谢学部的主任。他接替自 2014 年以来一直领导该部门的 Ira J. Goldberg, MD，并将继续担任教职。</p>
</div><p>Continue Reading</p>
<div class="lb-trans"><p>继续阅读</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null" alt="" original-src="https://www.prnewswire.com/news-releases/null"/></p>
<p>Marcus Goncalves, MD, PhD</p>
<div class="lb-trans"><p>Marcus Goncalves, MD, PhD</p>
</div><p>Dr. Goncalves joined NYU Langone in 2024 from Weill Cornell Medicine and NewYork-Presbyterian Hospital. He also serves as the Clarissa and Edgar Bronfman, Jr., Associate Professor of Endocrinology and director of Systemic Metabolism Research in the Department of Medicine at NYU Grossman School of Medicine, and as an associate professor in the Department of Radiation Oncology. A nationally recognized endocrinologist and physician-scientist, he leads a robust research program at the intersection of metabolism, cancer, and endocrine signaling. His work has advanced understanding of conditions including cachexia, obesity, insulin resistance, and the metabolic effects of dietary sugars such as fructose, with a consistent focus on translating discovery into better care for patients.</p>
<div class="lb-trans"><p>Goncalves 博士于 2024 年从威尔康奈尔医学院和纽约长老会医院加入纽约大学朗格尼。他还担任纽约大学格罗斯曼医学院内科学系的克拉丽莎和埃德加·布朗夫曼副教授及系统代谢研究主任，并在放射肿瘤学系担任副教授。作为一名全国知名的内分泌学家和医学科学家，他领导着一个强大的研究项目，专注于代谢、癌症和内分泌信号传导的交叉领域。他的研究推动了对包括恶病质、肥胖、胰岛素抵抗以及饮食糖（如果糖）代谢效应等疾病的理解，始终关注将发现转化为更好的患者护理。</p>
</div><p>&#34;Dr. Goncalves is an outstanding leader whose work exemplifies the integration of innovative research and clinical excellence,&#34; said Steven Abramson, MD, Frederick H. King Professor of Internal Medicine and chair of the Department of Medicine at NYU Grossman School of Medicine. &#34;He brings a forward-looking vision that will strengthen the division's academic profile while expanding its impact across patient care, education, and discovery.&#34;</p>
<div class="lb-trans"><p>“Goncalves 博士是一位杰出的领导者，他的工作体现了创新研究与临床卓越的结合，” 纽约大学格罗斯曼医学院内科学系的弗雷德里克·H·金内科学教授 Steven Abramson 博士说。“他带来了前瞻性的愿景，将增强该部门的学术形象，同时扩大其在患者护理、教育和发现方面的影响。”</p>
</div><p>As director, Dr. Goncalves will guide the division's clinical, research, and training missions. Priorities include enhancing NYU Langone's comprehensive programs in diabetes, thyroid, and pituitary disease; expanding multidisciplinary initiatives in bone health, obesity, and cancer-associated cachexia; and growing the portfolio of investigator-initiated and industry-sponsored clinical trials to accelerate the translation of scientific discovery into novel therapies.</p>
<div class="lb-trans"><p>作为主任，Goncalves 博士将指导该部门的临床、研究和培训任务。优先事项包括增强纽约大学朗格尼在糖尿病、甲状腺和垂体疾病方面的综合项目；扩大骨骼健康、肥胖和癌症相关恶病质的多学科倡议；以及增加研究者发起和行业赞助的临床试验组合，以加速科学发现向新疗法的转化。</p>
</div><p>&#34;I am honored to lead the division and to build on the extraordinary foundation established by Dr. Goldberg and our faculty,&#34; said Dr. Goncalves. &#34;Our goal is to bring the very best science to our patients — through innovative clinical trials, expanding and refining our subspecialty programs, and fostering multidisciplinary collaboration that leads to new therapies and better outcomes while reinforcing NYU Langone's position as a destination for complex endocrine care.&#34;</p>
<div class="lb-trans"><p>“我很荣幸能领导这个部门，并在 Goldberg 博士和我们的教职员工建立的卓越基础上继续发展，” Goncalves 博士说。“我们的目标是通过创新的临床试验、扩展和完善我们的亚专业项目，以及促进多学科合作，带来最好的科学成果，为我们的患者提供新疗法和更好的结果，同时巩固纽约大学朗格尼作为复杂内分泌护理目的地的地位。”</p>
</div><p>This leadership transition follows the distinguished tenure of Dr. Goldberg, who has overseen a period of exceptional growth and innovation for the Holman Division. Under his leadership, NYU Langone expanded access to endocrine care across Manhattan, Brooklyn, and Long Island; recruited a new generation of clinician-educators and physician-scientists; and advanced nationally recognized programs in diabetes, lipid disorders, thyroid disease, and pituitary and adrenal disorders. Under his leadership, NYU Langone has been ranked top 5 in the country for Diabetes and Endocrinology care by <em>U.S. News &amp; World Report</em> since 2021.</p>
<div class="lb-trans"><p>这一领导层的过渡是在 Goldberg 博士的杰出任期之后，他监督了霍尔曼部门的卓越增长和创新。在他的领导下，纽约大学朗格尼扩大了曼哈顿、布鲁克林和长岛的内分泌护理服务；招募了一代新的临床教育者和医学科学家；并推动了在糖尿病、脂质紊乱、甲状腺疾病以及垂体和肾上腺疾病方面的全国认可项目。在他的领导下，自 2021 年以来，纽约大学朗格尼在《美国新闻与世界报道》中被评为全国糖尿病和内分泌护理的前五名。</p>
</div><p>&#34;We are deeply grateful to Dr. Goldberg for his exceptional leadership and novel contributions to endocrinology,&#34; added Dr. Abramson. &#34;He has shaped a division that is at the forefront of clinical care and discovery. The strength of its clinical programs and research enterprise has positioned the division — and Dr. Goncalves — for continued success.&#34;</p>
<div class="lb-trans"><p>“我们对 Goldberg 博士的卓越领导和对内分泌学的新贡献深表感谢，” Abramson 博士补充道。“他塑造了一个处于临床护理和发现前沿的部门。其临床项目和研究企业的实力使该部门——以及 Goncalves 博士——能够继续取得成功。”</p>
</div><p>Building on this foundation, Dr. Goncalves will further develop programs at the interface of endocrinology and cancer, reflecting his research at the intersection of metabolism, cancer, and endocrine signaling. He will collaborate closely with his colleagues in oncology, radiation oncology, and other specialties to enhance care for patients with obesity, insulin resistance, cancer-associated cachexia, and other complex metabolic and endocrine disorders while expanding opportunities for translational and clinical research across NYU Langone.</p>
<div class="lb-trans"><p>在此基础上，Goncalves 博士将进一步发展内分泌学与癌症交叉领域的项目，反映他在代谢、癌症和内分泌信号传导交叉领域的研究。他将与肿瘤学、放射肿瘤学及其他专业的同事密切合作，以增强对肥胖、胰岛素抵抗、癌症相关恶病质及其他复杂代谢和内分泌疾病患者的护理，同时扩大纽约大学朗格尼的转化和临床研究机会。</p>
</div><p><strong>About NYU Langone Health</strong></p>
<div class="lb-trans"><p><strong>关于纽约大学朗格尼医疗中心</strong></p>
</div><p>NYU Langone Health is a fully integrated health system that consistently achieves the best patient outcomes through a rigorous focus on quality that has resulted in some of the lowest mortality rates in the nation. Vizient, Inc., has ranked NYU Langone No. 1 out of 118 comprehensive academic medical centers across the nation for four years in a row, and <em>U.S. News &amp; World Report</em> recently ranked four of its clinical specialties No. 1 in the nation. NYU Langone offers a comprehensive range of medical services with one high standard of care across seven inpatient locations, its Perlmutter Cancer Center, and more than 320 outpatient locations in the New York area and Florida. The system also includes two tuition-free medical schools, in Manhattan and on Long Island, and a vast research enterprise.</p>
<div class="lb-trans"><p>纽约大学朗格尼医疗中心是一个完全整合的健康系统，通过对质量的严格关注，始终实现最佳患者结果，导致其在全国拥有一些最低的死亡率。Vizient, Inc.已连续四年将纽约大学朗格尼评为全国 118 家综合学术医疗中心中的第一名，而《美国新闻与世界报道》最近将其四个临床专业评为全国第一。纽约大学朗格尼提供一系列全面的医疗服务，在七个住院地点、其 Perlmutter 癌症中心以及纽约地区和佛罗里达州的 320 多个门诊地点提供统一的高标准护理。该系统还包括两所免学费的医学院，分别位于曼哈顿和长岛，以及一个庞大的研究企业。</p>
</div><p><strong>Media Inquiries</strong></p>
<div class="lb-trans"><p><strong>媒体咨询</strong></p>
</div><p>Katie Ullman</p>
<div class="lb-trans"><p>Katie Ullman</p>
</div><p>Phone: 646-483-3984</p>
<div class="lb-trans"><p>电话：646-483-3984</p>
</div><p>[email protected]</p>
<div class="lb-trans"><p>[email protected]</p>
</div><p>SOURCE NYU Langone Health</p>
<div class="lb-trans"><p>来源：纽约大学朗格尼医疗中心</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMjE5Jk5ld3NJdGVtSWQ9UEg5MTc1OSZUcmFuc21pc3Npb25fSWQ9MjAyNjAyMTkxMzU4UFJfTkVXU19VU1BSX19fX19QSDkxNzU5" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=PH91759&amp;Transmission_Id=202602191358PR_NEWS_USPR_____PH91759&amp;DateId=20260219"/></p>

13:58 ET Marcus Goncalves 博士被任命为纽约大学朗格尼医学中心霍尔曼内分泌、糖尿病与代谢科主任